The proposals outline simplification "levers" to address sources of complexity in sustainability reporting under the EU Corporate Sustainability Reporting Directive.
The CFIUS report shows a continued decrease in the number of CFIUS filings, a decrease in the use of mitigation measures and conditions, and a focus on enforcement with record penalties.
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law.